These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12605967)
1. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma. Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967 [TBL] [Abstract][Full Text] [Related]
2. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification. Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R; Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001 [TBL] [Abstract][Full Text] [Related]
3. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience. De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG; J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
6. Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications. Yap LM; Blum R; Foley P; McCormack C; Turner H; Seymour JF; Prince HM Australas J Dermatol; 2003 May; 44(2):110-5. PubMed ID: 12752183 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy in the management of localized primary cutaneous B-cell lymphoma. Pashtan I; Mauch PM; Chen YH; Dorfman DM; Silver B; Ng AK Leuk Lymphoma; 2013 Apr; 54(4):726-30. PubMed ID: 22916994 [TBL] [Abstract][Full Text] [Related]
8. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients. Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311 [TBL] [Abstract][Full Text] [Related]
10. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. Rijlaarsdam JU; Toonstra J; Meijer OW; Noordijk EM; Willemze R J Clin Oncol; 1996 Feb; 14(2):549-55. PubMed ID: 8636770 [TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Akhtari M; Reddy JP; Pinnix CC; Allen PK; Osborne EM; Gunther JR; Milgrom SA; Smith GL; Wogan CF; Fowler N; Rodriguez MA; Dabaja B Leuk Lymphoma; 2016; 57(1):34-8. PubMed ID: 25860237 [TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification. Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204 [TBL] [Abstract][Full Text] [Related]
14. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa. Vandersee S; Terhorst D; Humme D; Beyer M J Am Acad Dermatol; 2014 Apr; 70(4):709-715. PubMed ID: 24433874 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742 [TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients. Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group. Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772 [TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086 [TBL] [Abstract][Full Text] [Related]